Filing Details
- Accession Number:
- 0001641172-25-003021
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-04-07 17:18:49
- Reporting Period:
- 2025-04-03
- Filing Date:
- 2025-04-07
- Accepted Time:
- 2025-04-07 17:18:49
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1834105 | Impact Biomedical Inc. | IBO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1261725 | Ambrose Fai Heng Chan | 9 Temasek Boulevard #16-04 Suntec Tower Two Singapore U0 038989 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2025-04-03 | 351,555 | $0.50 | 0 | No | 4 | S | Indirect | See footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | See footnote |
Footnotes
- On April 3, 2025, Alset International Limited sold 351,555 shares of the Issuer's common stock at a weighted average sale price of $0.495. This transaction was executed in multiple trades at prices ranging from $0.46 to $0.57. The reporting person hereby undertakes to provide, upon request of the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
- Mr. Chan is, personally and through an entity he controls, the majority shareholder of Alset Inc., and the Chairman and Chief Executive Officer of Alset Inc. Alset International Limited is a majority owned subsidiary of Alset Inc.
Billionaire Hedge Funds
